A.R.T. Advisors’s Altimmune ALT Stock Holding History

A.R.T. Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-28,324	Closed	-$55K	–	1311
2019 Q3	$55K	Buy	+28,324	New	+$62.8K	﹤0.01%	1310

Other funds holding ALT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

A.R.T. Advisors's ALT Position: Q4 2019 in Review

A.R.T. Advisors sold out of Altimmune (ALT) in Q4 2019, closing a stake of 28,324 shares — an estimated $55K sold.

A.R.T. Advisors first reported a position in ALT in Q3 2019 and held it in 1 quarter. The position peaked at $55K in Q3 2019. 28 funds tracked by Wall St. Rank hold ALT as of Q4 2019.

A.R.T. Advisors reported no remaining Altimmune position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 28,324 Altimmune shares in Q4 2019, an estimated $55K.
A.R.T. Advisors first reported a position in Altimmune in Q3 2019 and held it in 1 quarter.
A.R.T. Advisors's Altimmune position peaked at $55K in Q3 2019.
28 funds tracked by Wall St. Rank held Altimmune as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.